When you buy through our links, Business Insider may earn an affiliate commission. Learn more Though it typically costs $50 more than the digital-edition PS5, this model lets you play game discs and ...

PTC offers high-end computer-assisted design (Creo) and product lifecycle management (Windchill) software as well as augmented reality industrial solutions. Founded in 1985, PTC has 28,000 customers, ...

Earlier this month, PTC announced that HOLON, a BENTELER Group subsidiary, adopted its Windchill+ cloud PLM to develop a Level-4 autonomous EV, while PTC also introduced an AI Engine for its Arena PLM ...

Hey, I’m Ealan Osborne 🎬🎶 Passionate about movies, music, and all things sound! Follow for honest reviews on the latest music, home theater setups, sound systems, and surround sound tech. Let’s dive ...

Artificial intelligence and related technologies are evolving rapidly, but until recently, Java developers had few options for integrating AI capabilities directly into Spring-based applications.

Spring Boot is one of the most popular and accessible web development frameworks in the world. Find out what it’s about, with this quick guide to web development with Spring Boot. Spring’s most ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...

TPG has agreed to acquire PTC’s industrial connectivity and IoT businesses. No financial terms were disclosed. Headquartered in Boston, PTC is a software company. Neil Barua serves as president and ...

The premium tax credit is a refundable credit that helps some taxpayers afford health insurance premiums. The advance PTC lowers the premiums themselves. Many, or all, of the products featured on this ...

If Wall Street had any doubts about Neil Barua filling the shoes of his predecessor Jim Heppelmann as chief executive at PTC, those doubts went out the (computer-designed) window last week. The Boston ...

Shares of PTC Therapeutics climbed after the company said federal regulators approved its treatment for elevated levels of a certain amino acid in the blood. The stock was up 11%, at $49.08, midday ...